United States · Series B startup

Who invested in Mingsight Pharmaceuticals

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$20Mraised across 1 round since 2021, from 1 source

Latest round
Series B, $20MNov 2021
Investors
1
See who backed them

The rounds

  1. Nov 2021
    Series B$20M

    Source recordedSEC filing: $10.0M sold, first sale Nov 2021

Everyone who backed them

Kaitai CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Mingsight Pharmaceuticals

Who invested in Mingsight Pharmaceuticals?

Mingsight Pharmaceuticals's investors include Kaitai Capital.

How much has Mingsight Pharmaceuticals raised?

Mingsight Pharmaceuticals has raised $20M across 1 round since 2021.

When did Mingsight Pharmaceuticals last raise?

Mingsight Pharmaceuticals's most recent round was a Series B of $20M in Nov 2021.

What was Mingsight Pharmaceuticals's biggest round?

Its most recent round, $20M in Nov 2021, is also its largest on record.

Who backed Mingsight Pharmaceuticals first?

Mingsight Pharmaceuticals's first round on record, in Nov 2021, was backed by Kaitai Capital.

What stage is Mingsight Pharmaceuticals at?

Mingsight Pharmaceuticals's latest named round is a Series B, in Nov 2021.

Where is Mingsight Pharmaceuticals based?

Mingsight Pharmaceuticals is based in the United States.

Companies like Mingsight Pharmaceuticals

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.